当前位置: X-MOL 学术EMBO J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
ATP citrate lyase controls hematopoietic stem cell fate and supports bone marrow regeneration.
The EMBO Journal ( IF 11.4 ) Pub Date : 2022-03-01 , DOI: 10.15252/embj.2021109463
Terumasa Umemoto 1 , Alban Johansson 1 , Shah Adil Ishtiyaq Ahmad 1 , Michihiro Hashimoto 2 , Sho Kubota 3 , Kenta Kikuchi 4 , Haruki Odaka 5 , Takumi Era 5 , Daisuke Kurotaki 4 , Goro Sashida 3 , Toshio Suda 2, 6
Affiliation  

In order to support bone marrow regeneration after myeloablation, hematopoietic stem cells (HSCs) actively divide to provide both stem and progenitor cells. However, the mechanisms regulating HSC function and cell fate choice during hematopoietic recovery remain unclear. We herein provide novel insights into HSC regulation during regeneration by focusing on mitochondrial metabolism and ATP citrate lyase (ACLY). After 5-fluorouracil-induced myeloablation, HSCs highly expressing endothelial protein C receptor (EPCRhigh ) were enriched within the stem cell fraction at the expense of more proliferative EPCRLow HSCs. These EPCRHigh HSCs were initially more primitive than EPCRLow HSCs and enabled stem cell expansion by enhancing histone acetylation, due to increased activity of ACLY in the early phase of hematopoietic regeneration. In the late phase of recovery, HSCs enhanced differentiation potential by increasing the accessibility of cis-regulatory elements in progenitor cell-related genes, such as CD48. In conditions of reduced mitochondrial metabolism and ACLY activity, these HSCs maintained stem cell phenotypes, while ACLY-dependent histone acetylation promoted differentiation into CD48+ progenitor cells. Collectively, these results indicate that the dynamic control of ACLY-dependent metabolism and epigenetic alterations is essential for HSC regulation during hematopoietic regeneration.

中文翻译:

ATP 柠檬酸裂合酶控制造血干细胞命运并支持骨髓再生。

为了支持清髓后的骨髓再生,造血干细胞 (HSC) 积极分裂以提供干细胞和祖细胞。然而,在造血恢复过程中调节 HSC 功能和细胞命运选择的机制仍不清楚。我们在此通过关注线粒体代谢和 ATP 柠檬酸裂解酶 (ACLY),提供了对再生过程中 HSC 调节的新见解。在 5-氟尿嘧啶诱导的骨髓清除后,高表达内皮蛋白 C 受体 (EPCRhigh ) 的 HSC 在干细胞部分中富集,但以更具增殖性的 EPCRLow HSC 为代价。这些 EPCRHigh HSCs 最初比 EPCRLow HSCs 更原始,并且由于造血再生早期 ACLY 活性增加,通过增强组蛋白乙酰化使干细胞扩增。在恢复后期,HSC 通过增加祖细胞相关基因(如 CD48)中顺式调节元件的可及性来增强分化潜能。在线粒体代谢和 ACLY 活性降低的情况下,这些 HSC 保持干细胞表型,而 ACLY 依赖性组蛋白乙酰化促进分化为 CD48+ 祖细胞。总的来说,这些结果表明,ACLY 依赖性代谢和表观遗传改变的动态控制对于造血再生过程中的 HSC 调节至关重要。而 ACLY 依赖性组蛋白乙酰化促进分化为 CD48+ 祖细胞。总的来说,这些结果表明,ACLY 依赖性代谢和表观遗传改变的动态控制对于造血再生过程中的 HSC 调节至关重要。而 ACLY 依赖性组蛋白乙酰化促进分化为 CD48+ 祖细胞。总的来说,这些结果表明,ACLY 依赖性代谢和表观遗传改变的动态控制对于造血再生过程中的 HSC 调节至关重要。
更新日期:2022-03-01
down
wechat
bug